A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders (Q48868283)

16 February 2018

title

A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders (English)

1 reference

16 February 2018

Marco Bigelli

4

0 references

Emanuele Bajo

object named as

Emanuele Bajo

3

0 references

Paolo Olgiati

object named as

Paolo Olgiati

2

0 references

Alessandro Serretti

object named as

Alessandro Serretti

1

0 references

author name string

Diana De Ronchi

5

1 reference

16 February 2018

publication date

19 May 2011

1 reference

16 February 2018

World Journal of Biological Psychiatry

published in

1 reference

16 February 2018

volume

12

1 reference

16 February 2018

issue

7

1 reference

16 February 2018

page(s)

501-515

1 reference

16 February 2018

Job performance deficits due to depression

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Pharmacogenetics in psychiatry: are we ready for widespread clinical use?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

The effectiveness of cost-effectiveness analysis in containing costs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Practice patterns and hospitalization rates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Depression and the workplace: a progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Determinants of direct cost differences among US employees with major depressive disorders using antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Pharmacogenetics of antidepressant response: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

A guide to cost-effectiveness acceptability curves.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Factors Influencing Depression Endpoints Research (FINDER): baseline results of Italian patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Moderation of antidepressant response by the serotonin transporter gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

A systematic review of long-term studies of drug treated and non-drug treated depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

"A gene for...": the nature of gene action in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Depressive symptoms and 10-year risk for cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Pharmacogenetics studies in STAR*D: strengths, limitations, and results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

SLC6A4 variation and citalopram response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Gene X environment interactions at the serotonin transporter locus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

How accurate are patients in reporting their antidepressant treatment history?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Outcome and length of stay in psychiatric hospitalization, the experience of the University Clinic of Turin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Functional and work disability in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Persistence and compliance to antidepressant treatment in patients with depression: a chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Pharmacogenetics in the treatment of depression: pharmacodynamic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Pharmacogenetic studies in depression: a proposal for methodologic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Antidepressant response and the serotonin transporter gene-linked polymorphic region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

TPH and suicidal behavior: a study in suicide completers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Placebo response in studies of major depression: variable, substantial, and growing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

Long-term suicide risk of depression in the Lundby cohort 1947–1997 – severity and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.572998

10.3109/15622975.2011.572998

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018